Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

407.83 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

69 70 Next >

Demystifying Amgen: Insights From 13 Analyst Reviews ↗

December 10, 2024

Via Benzinga

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer ↗

December 09, 2024

Via The Motley Fool

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

December 07, 2024

Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.

Via The Motley Fool

Topics Stocks

MarketBeat Week in Review – 12/2 - 12/6

December 07, 2024

Equities continued their post-election rally after Friday’s solid November jobs report and all signs point to the rally in stocks extending into 2025

Via MarketBeat

Topics Economy Government Immigration

Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

December 06, 2024

Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.

Via MarketBeat

Is Amgen Still a Top Dividend Stock? ↗

December 05, 2024

Via The Motley Fool

This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip? ↗

December 02, 2024

Via The Motley Fool

13 Healthcare Sector Stocks With Healthy Valuation ↗

December 05, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...

Via Talk Markets

Topics Stocks Stocks / Equities

10 Health Care Stocks Whale Activity In Today's Session ↗

December 05, 2024

Via Benzinga

This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy? ↗

December 05, 2024

Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.

Via The Motley Fool

Eli Lilly Just Got a Bundle of Good News: Time to Buy? ↗

December 04, 2024

Via The Motley Fool

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance ↗

December 03, 2024

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a $100B market.

Via Benzinga

Why Amgen's Weight Loss Result Is a Win for Eli Lilly ↗

November 27, 2024

Via The Motley Fool

Decoding Amgen's Options Activity: What's the Big Picture? ↗

November 20, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 02, 2024

Via Benzinga

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy? ↗

November 30, 2024

Via The Motley Fool

Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review ↗

November 29, 2024

The Nasdaq isn't at a high, but it isn't far off either.

Via Investor's Business Daily

Topics Government

Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? ↗

November 29, 2024

Via The Motley Fool

2 Generic Drug Stocks Ready to Surge in 2025

November 27, 2024

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

Via MarketBeat

Topics Government Intellectual Property

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday? ↗

November 26, 2024

The U.S. stock market traded mixed on Tuesday morning, with major indices showing tight movements as investors awaited the release of the Federal Reserve's November meeting minutes.

Via Benzinga

Topics Economy

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs ↗

November 26, 2024

The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis.

Via Benzinga

Pain In Retail ↗

November 26, 2024

It’s been a relatively busy morning for earnings, especially from retailers. Of the ten companies reporting, six topped EPS forecasts, seven beat sales forecasts, but two, Best Buy and Kohl’s lowered...

Via Talk Markets

Topics Stocks / Equities

Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test ↗

November 26, 2024

Over the course of a year, Amgen's MariTide helped patients lose about 20% of their body weight.

Via Investor's Business Daily

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau ↗

November 26, 2024

Amgen's Phase 2 MariTide trial showed ~20% weight loss at 52 weeks, cardiometabolic improvements, and no significant safety issues.

Via Benzinga

Investing in Pharma Stocks? Check These 3 Things First ↗

November 22, 2024

Via The Motley Fool

Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry? ↗

November 22, 2024

Robert F. Kennedy hasn't overtly commented on how he would handle GLP-1 drugs. But there are hints.

Via Investor's Business Daily

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs ↗

November 21, 2024

LLY stock struggles, falling 16.85% over the last month due to bearish technicals and political uncertainty. But with projected sales and earnings growth, could this be a buying opportunity?

Via Benzinga

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst ↗

November 19, 2024

Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.

Via Benzinga

Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 18, 2024

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.